2025 Silent Capital Report now available. Where family offices and LPs are actually deploying. [Download for free →]
About usSign in
Status
ACTIVE
Global HQ
San Francisco, United States
Countries of investment
  • United States
  • Canada
  • United Kingdom
  • Israel
  • Germany
  • France
Investment stages
  • Pre-Seed
  • Seed
  • Series A
Industries
  • Biotech
  • Climate Tech
  • Hardware
  • Deep Tech
  • Frontier Tech
  • Synthetic Biology
  • Robotics
About
Refactor Capital is a San Francisco-based VC focused on early-stage hard tech and biotech startups. Their focus spans biotech, climate tech, hardware, deep tech, and frontier tech across the United States, Canada, the United Kingdom, Israel, Germany, and France. The firm supports technical founders from Pre-Seed through Series A.
Min check size
$1M
Max check size
$2M
Fund size
NPS

Investment Thesis

Refactor Capital is an early-stage venture capital firm deploying capital across biotech, climate tech, hardware, deep tech, and frontier technology sectors. They invest in founders working on hard problems that matter — bioengineering, climate, computing, and human health — with patient capital and technical conviction. The firm differentiates itself through founders Zal Bilimoria and David Lee's deep technical investing expertise, dedicated focus on hard tech and science-led founders, and operator-investor support spanning biotech and frontier tech ecosystems.
Lead investor
Co Invest
Number of exits
Preferred contact method

Manager's Experience

Zal Bilimoria (Co-Founder & Partner) co-founded Refactor Capital after serving as a Partner at Andreessen Horowitz where he led investments across biotech and frontier tech; he previously worked in product roles at YouTube and Netflix. David Lee (Co-Founder & Partner) co-founded the firm bringing deep operator-investor expertise from his prior role as Founding Partner at SV Angel and Y Combinator advisor. The team has built a track record investing in hard tech and biotech founders working on problems that matter across bioengineering, climate, computing, and human health.

Refactor Capital Contacts Information

Primary contact

Secondary contact

Team

Zal Bilimoria - Founding Partner & Solo GP

Portfolio

Solugen

Astranis

Biorender

Curative

PathAI

Akasa

Hexium

Brelle

Epana Bio

Causal Labs

General Galactic

Inferra

64-X Bio

Adventris

Berkeley Yeast

Checkerspot

Coinbase

Floodbase

Granza Bio

Headspace

Knowde

Loyal

Macro Oceans

Miist

Octant

Onyx Bio

Ophelia

Orchid Health

Parallel Bio

Phytoform

Picnic Health

Pila Energy

Pilgrim

Remedy Scientific

Thalo Labs

Vital Health

Vitra Labs

YourChoice

Clover Health

Lucy

Atlas

Fund number
Vintage Year
Net Internal Rate of Return
Investment Multiple
Capital Allocation
Management Fee
Carried Interest
AUM
Follow-on Investments
Graduation Rate
Write-Off Ratio
Last profile update timestamp